CASTLE CREEK BIOSCIENCES
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.
CASTLE CREEK BIOSCIENCES
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2015-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.castlecreekbio.com
Total Employee:
11+
Status:
Active
Contact:
(484) 713-6133
Email Addresses:
[email protected]
Total Funding:
309.43 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Artizan Biosciences
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Dermira
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
HDT Bio
IMMUNE THERAPY FOR ALL: We’re transforming inventive immunotherapies for oncology and infectious disease.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Life Biosciences
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Nuclera
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Orphion Therapeutics
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
SuperBrewed Food
SuperBrewed Food(formerlyWhite Dog Labs) is developing new probiotics for animals and human.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-10 | Cytotheryx | Cytotheryx acquired by Castle Creek Biosciences | N/A |
| 2019-09-12 | Fibrocell Science | Fibrocell Science acquired by Castle Creek Biosciences | N/A |
Investors List
Valor Equity Partners
Valor Equity Partners investment in Venture Round - Castle Creek Biosciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Castle Creek Biosciences
Paragon Biosciences
Paragon Biosciences investment in Venture Round - Castle Creek Biosciences
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - Castle Creek Biosciences
Paragon Biosciences
Paragon Biosciences investment in Venture Round - Castle Creek Biosciences
Horizon Technology Finance
Horizon Technology Finance investment in Debt Financing - Castle Creek Biosciences
Valor Equity Partners
Valor Equity Partners investment in Venture Round - Castle Creek Biosciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Castle Creek Biosciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Castle Creek Biosciences
Valor Equity Partners
Valor Equity Partners investment in Venture Round - Castle Creek Biosciences
Official Site Inspections
http://www.castlecreekbio.com Semrush global rank: 3.48 M Semrush visits lastest month: 4.31 K
- Host name: 211.239.154.104.bc.googleusercontent.com
- IP address: 104.154.239.211
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Castle Creek Biosciences"
Castle Creek: The Leader in Autologous Fibroblast Therapies
D-fi
The DeFi-RDEB Phase 3 study is evaluating the safety and efficacy of FCX-007 (debcoemagene autoficel), an investigational gene therapy for the localized treatmeSee details»
Contact Us - Castle Creek Biosciences, Inc.
For More Information Castle Creek Biosciences Headquarters 405 Eagleview Boulevard Exton, PA 19341 484.352.3055 Media Inquiries Sheridan Chaney 312.847.1323 [email protected] Medical Information For information …See details»
About the D-Fi study – D-fi - d-fi.castlecreekbio.com
What is D-Fi? Castle Creek Biosciences is using its proprietary fibroblast technology platform to develop and evaluate D-Fi. It is an innovative personalized treatment that is compatible with a …See details»
Castle Creek Biosciences - Crunchbase Company …
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.See details»
Contact Us – D-fi
If you have additional questions about the CCB-EB-304 study, need help finding a study location, or would like to report an issue with this website, please complete the following form (all fields …See details»
Castle Creek Biosciences, Inc. | LinkedIn
Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic ...See details»
Castle Creek Biosciences - Company Profile - Tracxn
Nov 15, 2024 What are the most recent funding rounds of Castle Creek Biosciences? Its latest funding round was a Series D round on Jan 18, 2022 for $113M. 2 investors participated in its …See details»
Dedicated to making life better for people with rare and serious …
Castlecreekbio.com “We believe our experience, expertise and proven processes provide us with the capability to deliver potentially transformative, localized therapies to these patients. We …See details»
Castle Creek Biosciences, LLC Details - govtribe.com
Dec 23, 2021 (Click to sort descending) R01FD007289: Castle Creek Biosciences, LLC: Project Grant: $1.0m: 9/10/21: 6/19/23: A PIVOTAL PHASE 3 STUDY OF FCX-007 (GENETICALLY …See details»
Castle Creek Biosciences - Overview, News & Similar ... - ZoomInfo
Nov 1, 2021 Castle Creek Biosciences contact info: Phone number: (484) 713-6000 Website: www.castlecreekbio.com What does Castle Creek Biosciences do? Castle Creek Biosciences, …See details»
Castle Creek Biosciences, Inc. Overview - SignalHire
Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic …See details»
Castle Creek Biosciences - Craft
Castle Creek Biosciences has 5 employees at their 1 location and $174.8 m in total funding,. See insights on Castle Creek Biosciences including office locations, competitors, revenue, …See details»
Castle Creek: Experience, Expertise and Proven Processes
Dedicated to developing therapies that address unmet needs of patients with rare diseases with the goal of making a positive difference in their lives.See details»
Jeff Aronin Announces Matthew Gantz as CEO of Castle
May 11, 2021 Castle Creek Biosciences recently announced the appointment of Matthew Gantz as the organization’s President and Chief Executive Officer. The appointment will also include …See details»
Castle Creek Biosciences | Exton PA - Facebook
Castle Creek Biosciences, Exton, Pennsylvania. 162 likes · 1 was here. Dedicated to making life better for people living with genetic diseases.See details»
Cell and Gene Therapy Innovator Castle Creek Biosciences …
Apr 20, 2021 The Company operates an in-house commercial scale facility located in Exton, Pennsylvania, which is designed to be current good manufacturing practices-compliant …See details»
Castle Creek Biosciences Raises $112.8 Million to Advance Novel …
EXTON, Pennsylvania– May 25, 2022 – Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company using two lentiviral platforms to develop and commercialize therapies …See details»
Dedicated to making life better for people living with underserved ...
Castlecreekbio.com “We believe our experience, expertise and proven processes provide us with an opportunity to develop and evaluate new personalized therapies that are designed for …See details»